Tang Jinlu, Lei Yanli, He Xiaoxiao, Liu Jianbo, Shi Hui, Wang Kemin
State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Changsha 410082, P. R. China.
Department of Histology and Embryology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, P. R. China.
Anal Chem. 2020 Aug 4;92(15):10839-10846. doi: 10.1021/acs.analchem.0c02524. Epub 2020 Jul 15.
Proximity-dependent hybridization chain reaction (HCR) has shown great potential in sensing biomolecules on the cell surface. However, the requirement of two adjacent bioevents occurring simultaneously limits its application. To solve the problem, split aptamers with target binding ability were introduced to combine with split triggers for initiating HCR, thus producing a novel dual-split aptamer probe (DSAP). By employing cancer-related receptors as models, in situ HCR on a cancer cell surface induced by recognition-driven remodeling of the DSAP was demonstrated. The DSAP consisted of two sequences. Each contained two segments; one derived from split aptamers and the other originated in split triggers. In the presence of target cells, split aptamers reassembled on the cell surface under the "induced-fit effect", thus forcing two split triggers close to each other. The remodeled DSAP worked as an intact trigger, which opened the H1 hairpin probe and then hybridized with the H2 hairpin probe, thus initiating HCR to produce an activated fluorescence signal. As a proof of concept, human liver cancer SMMC-7721 cells and their split ZY11 aptamer were used to construct the DSAP. Results indicated that the DSAP realized sensitive analysis of target cells, permitting the actual detection of 20 cells in the buffer. Moreover, the specific identification of target cells in mixed cell samples and the quantitative analysis of target cells in serum were also achieved. The DSAP strategy is facile and universal, which not only would expand the application range of HCR but also might be developed as a multitarget detection technique for bioanalysis.
邻近依赖性杂交链式反应(HCR)在检测细胞表面生物分子方面已显示出巨大潜力。然而,两个相邻生物事件同时发生的要求限制了其应用。为了解决这个问题,引入了具有靶标结合能力的分裂适体,与分裂触发子结合以启动HCR,从而产生了一种新型的双分裂适体探针(DSAP)。以癌症相关受体为模型,证明了由DSAP的识别驱动重塑在癌细胞表面诱导的原位HCR。DSAP由两个序列组成。每个序列包含两个片段;一个来自分裂适体,另一个源自分裂触发子。在存在靶细胞的情况下,分裂适体在“诱导契合效应”下在细胞表面重新组装,从而迫使两个分裂触发子彼此靠近。重塑后的DSAP作为完整的触发子,打开H1发夹探针,然后与H2发夹探针杂交,从而启动HCR以产生激活的荧光信号。作为概念验证,使用人肝癌SMMC-7721细胞及其分裂的ZY11适体构建了DSAP。结果表明,DSAP实现了对靶细胞的灵敏分析,能够在缓冲液中实际检测到20个细胞。此外,还实现了对混合细胞样品中靶细胞的特异性鉴定以及血清中靶细胞的定量分析。DSAP策略简便且通用,不仅会扩大HCR的应用范围,还可能发展成为一种用于生物分析的多靶点检测技术。